Global Sirolimus Eluting Coronary Stent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 102
Published Date: 04 Aug 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
According to our (Global Info Research) latest study, the global Sirolimus Eluting Coronary Stent market size was valued at USD 105 million in 2022 and is forecast to a readjusted size of USD 132.2 million by 2029 with a CAGR of 3.3% during review period.
Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.
The sirolimus-eluting coronary stent is a medical device used in interventional cardiovascular surgery and belongs to a type of drug-eluting stent. A coronary stent is a device used to treat narrowed or blocked coronary arteries that is placed in the coronary arteries by percutaneous coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI). A stent can help restore patency to blood vessels so blood flow can resume. Sirolimus is an immunosuppressant that inhibits cell proliferation. A sirolimus-eluting coronary stent is a drug-eluting stent whose surface is coated with the drug sirolimus. When a stent is placed in a narrowed coronary artery, sirolimus is gradually eluted and released onto the vessel wall. The drug release of sirolimus helps to inhibit cell proliferation within blood vessels, reducing the risk of restenosis, thereby increasing the long-lasting effect of the procedure.
The Global Info Research report includes an overview of the development of the Sirolimus Eluting Coronary Stent industry chain, the market status of Hospitals (Balloon Diameter 2.25-3 mm, Balloon Diameter 3-4 mm), Clinics (Balloon Diameter 2.25-3 mm, Balloon Diameter 3-4 mm), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Sirolimus Eluting Coronary Stent.
Regionally, the report analyzes the Sirolimus Eluting Coronary Stent markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Sirolimus Eluting Coronary Stent market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Sirolimus Eluting Coronary Stent market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Sirolimus Eluting Coronary Stent industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Balloon Diameter 2.25-3 mm, Balloon Diameter 3-4 mm).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Sirolimus Eluting Coronary Stent market.
Regional Analysis: The report involves examining the Sirolimus Eluting Coronary Stent market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Sirolimus Eluting Coronary Stent market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Sirolimus Eluting Coronary Stent:
Company Analysis: Report covers individual Sirolimus Eluting Coronary Stent manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Sirolimus Eluting Coronary Stent This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Sirolimus Eluting Coronary Stent. It assesses the current state, advancements, and potential future developments in Sirolimus Eluting Coronary Stent areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Sirolimus Eluting Coronary Stent market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Sirolimus Eluting Coronary Stent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Balloon Diameter 2.25-3 mm
Balloon Diameter 3-4 mm
Others
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Cardionovum
Concept Medical
BIOTRONIK
Terumo Europe
Meril Life Sciences
eucatech AG
Eurocor Tech
MedAlliance
Boston Scientific
Abbott
Vasmed
Alvimedica
B. Braun
Balton
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sirolimus Eluting Coronary Stent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sirolimus Eluting Coronary Stent, with price, sales, revenue and global market share of Sirolimus Eluting Coronary Stent from 2018 to 2023.
Chapter 3, the Sirolimus Eluting Coronary Stent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sirolimus Eluting Coronary Stent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Sirolimus Eluting Coronary Stent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sirolimus Eluting Coronary Stent.
Chapter 14 and 15, to describe Sirolimus Eluting Coronary Stent sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Sirolimus Eluting Coronary Stent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Sirolimus Eluting Coronary Stent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Balloon Diameter 2.25-3 mm
1.3.3 Balloon Diameter 3-4 mm
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Sirolimus Eluting Coronary Stent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Sirolimus Eluting Coronary Stent Market Size & Forecast
1.5.1 Global Sirolimus Eluting Coronary Stent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Sirolimus Eluting Coronary Stent Sales Quantity (2018-2029)
1.5.3 Global Sirolimus Eluting Coronary Stent Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Cardionovum
2.1.1 Cardionovum Details
2.1.2 Cardionovum Major Business
2.1.3 Cardionovum Sirolimus Eluting Coronary Stent Product and Services
2.1.4 Cardionovum Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Cardionovum Recent Developments/Updates
2.2 Concept Medical
2.2.1 Concept Medical Details
2.2.2 Concept Medical Major Business
2.2.3 Concept Medical Sirolimus Eluting Coronary Stent Product and Services
2.2.4 Concept Medical Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Concept Medical Recent Developments/Updates
2.3 BIOTRONIK
2.3.1 BIOTRONIK Details
2.3.2 BIOTRONIK Major Business
2.3.3 BIOTRONIK Sirolimus Eluting Coronary Stent Product and Services
2.3.4 BIOTRONIK Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BIOTRONIK Recent Developments/Updates
2.4 Terumo Europe
2.4.1 Terumo Europe Details
2.4.2 Terumo Europe Major Business
2.4.3 Terumo Europe Sirolimus Eluting Coronary Stent Product and Services
2.4.4 Terumo Europe Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Terumo Europe Recent Developments/Updates
2.5 Meril Life Sciences
2.5.1 Meril Life Sciences Details
2.5.2 Meril Life Sciences Major Business
2.5.3 Meril Life Sciences Sirolimus Eluting Coronary Stent Product and Services
2.5.4 Meril Life Sciences Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Meril Life Sciences Recent Developments/Updates
2.6 eucatech AG
2.6.1 eucatech AG Details
2.6.2 eucatech AG Major Business
2.6.3 eucatech AG Sirolimus Eluting Coronary Stent Product and Services
2.6.4 eucatech AG Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 eucatech AG Recent Developments/Updates
2.7 Eurocor Tech
2.7.1 Eurocor Tech Details
2.7.2 Eurocor Tech Major Business
2.7.3 Eurocor Tech Sirolimus Eluting Coronary Stent Product and Services
2.7.4 Eurocor Tech Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Eurocor Tech Recent Developments/Updates
2.8 MedAlliance
2.8.1 MedAlliance Details
2.8.2 MedAlliance Major Business
2.8.3 MedAlliance Sirolimus Eluting Coronary Stent Product and Services
2.8.4 MedAlliance Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 MedAlliance Recent Developments/Updates
2.9 Boston Scientific
2.9.1 Boston Scientific Details
2.9.2 Boston Scientific Major Business
2.9.3 Boston Scientific Sirolimus Eluting Coronary Stent Product and Services
2.9.4 Boston Scientific Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Boston Scientific Recent Developments/Updates
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business
2.10.3 Abbott Sirolimus Eluting Coronary Stent Product and Services
2.10.4 Abbott Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Abbott Recent Developments/Updates
2.11 Vasmed
2.11.1 Vasmed Details
2.11.2 Vasmed Major Business
2.11.3 Vasmed Sirolimus Eluting Coronary Stent Product and Services
2.11.4 Vasmed Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Vasmed Recent Developments/Updates
2.12 Alvimedica
2.12.1 Alvimedica Details
2.12.2 Alvimedica Major Business
2.12.3 Alvimedica Sirolimus Eluting Coronary Stent Product and Services
2.12.4 Alvimedica Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Alvimedica Recent Developments/Updates
2.13 B. Braun
2.13.1 B. Braun Details
2.13.2 B. Braun Major Business
2.13.3 B. Braun Sirolimus Eluting Coronary Stent Product and Services
2.13.4 B. Braun Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 B. Braun Recent Developments/Updates
2.14 Balton
2.14.1 Balton Details
2.14.2 Balton Major Business
2.14.3 Balton Sirolimus Eluting Coronary Stent Product and Services
2.14.4 Balton Sirolimus Eluting Coronary Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Balton Recent Developments/Updates
3 Competitive Environment: Sirolimus Eluting Coronary Stent by Manufacturer
3.1 Global Sirolimus Eluting Coronary Stent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Sirolimus Eluting Coronary Stent Revenue by Manufacturer (2018-2023)
3.3 Global Sirolimus Eluting Coronary Stent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Sirolimus Eluting Coronary Stent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Sirolimus Eluting Coronary Stent Manufacturer Market Share in 2022
3.4.2 Top 6 Sirolimus Eluting Coronary Stent Manufacturer Market Share in 2022
3.5 Sirolimus Eluting Coronary Stent Market: Overall Company Footprint Analysis
3.5.1 Sirolimus Eluting Coronary Stent Market: Region Footprint
3.5.2 Sirolimus Eluting Coronary Stent Market: Company Product Type Footprint
3.5.3 Sirolimus Eluting Coronary Stent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Sirolimus Eluting Coronary Stent Market Size by Region
4.1.1 Global Sirolimus Eluting Coronary Stent Sales Quantity by Region (2018-2029)
4.1.2 Global Sirolimus Eluting Coronary Stent Consumption Value by Region (2018-2029)
4.1.3 Global Sirolimus Eluting Coronary Stent Average Price by Region (2018-2029)
4.2 North America Sirolimus Eluting Coronary Stent Consumption Value (2018-2029)
4.3 Europe Sirolimus Eluting Coronary Stent Consumption Value (2018-2029)
4.4 Asia-Pacific Sirolimus Eluting Coronary Stent Consumption Value (2018-2029)
4.5 South America Sirolimus Eluting Coronary Stent Consumption Value (2018-2029)
4.6 Middle East and Africa Sirolimus Eluting Coronary Stent Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2029)
5.2 Global Sirolimus Eluting Coronary Stent Consumption Value by Type (2018-2029)
5.3 Global Sirolimus Eluting Coronary Stent Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2029)
6.2 Global Sirolimus Eluting Coronary Stent Consumption Value by Application (2018-2029)
6.3 Global Sirolimus Eluting Coronary Stent Average Price by Application (2018-2029)
7 North America
7.1 North America Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2029)
7.2 North America Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2029)
7.3 North America Sirolimus Eluting Coronary Stent Market Size by Country
7.3.1 North America Sirolimus Eluting Coronary Stent Sales Quantity by Country (2018-2029)
7.3.2 North America Sirolimus Eluting Coronary Stent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2029)
8.2 Europe Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2029)
8.3 Europe Sirolimus Eluting Coronary Stent Market Size by Country
8.3.1 Europe Sirolimus Eluting Coronary Stent Sales Quantity by Country (2018-2029)
8.3.2 Europe Sirolimus Eluting Coronary Stent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Sirolimus Eluting Coronary Stent Market Size by Region
9.3.1 Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Sirolimus Eluting Coronary Stent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2029)
10.2 South America Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2029)
10.3 South America Sirolimus Eluting Coronary Stent Market Size by Country
10.3.1 South America Sirolimus Eluting Coronary Stent Sales Quantity by Country (2018-2029)
10.3.2 South America Sirolimus Eluting Coronary Stent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Sirolimus Eluting Coronary Stent Market Size by Country
11.3.1 Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Sirolimus Eluting Coronary Stent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Sirolimus Eluting Coronary Stent Market Drivers
12.2 Sirolimus Eluting Coronary Stent Market Restraints
12.3 Sirolimus Eluting Coronary Stent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Sirolimus Eluting Coronary Stent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Sirolimus Eluting Coronary Stent
13.3 Sirolimus Eluting Coronary Stent Production Process
13.4 Sirolimus Eluting Coronary Stent Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Sirolimus Eluting Coronary Stent Typical Distributors
14.3 Sirolimus Eluting Coronary Stent Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Sirolimus Eluting Coronary Stent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Sirolimus Eluting Coronary Stent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Cardionovum Basic Information, Manufacturing Base and Competitors
Table 4. Cardionovum Major Business
Table 5. Cardionovum Sirolimus Eluting Coronary Stent Product and Services
Table 6. Cardionovum Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Cardionovum Recent Developments/Updates
Table 8. Concept Medical Basic Information, Manufacturing Base and Competitors
Table 9. Concept Medical Major Business
Table 10. Concept Medical Sirolimus Eluting Coronary Stent Product and Services
Table 11. Concept Medical Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Concept Medical Recent Developments/Updates
Table 13. BIOTRONIK Basic Information, Manufacturing Base and Competitors
Table 14. BIOTRONIK Major Business
Table 15. BIOTRONIK Sirolimus Eluting Coronary Stent Product and Services
Table 16. BIOTRONIK Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BIOTRONIK Recent Developments/Updates
Table 18. Terumo Europe Basic Information, Manufacturing Base and Competitors
Table 19. Terumo Europe Major Business
Table 20. Terumo Europe Sirolimus Eluting Coronary Stent Product and Services
Table 21. Terumo Europe Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Terumo Europe Recent Developments/Updates
Table 23. Meril Life Sciences Basic Information, Manufacturing Base and Competitors
Table 24. Meril Life Sciences Major Business
Table 25. Meril Life Sciences Sirolimus Eluting Coronary Stent Product and Services
Table 26. Meril Life Sciences Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Meril Life Sciences Recent Developments/Updates
Table 28. eucatech AG Basic Information, Manufacturing Base and Competitors
Table 29. eucatech AG Major Business
Table 30. eucatech AG Sirolimus Eluting Coronary Stent Product and Services
Table 31. eucatech AG Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. eucatech AG Recent Developments/Updates
Table 33. Eurocor Tech Basic Information, Manufacturing Base and Competitors
Table 34. Eurocor Tech Major Business
Table 35. Eurocor Tech Sirolimus Eluting Coronary Stent Product and Services
Table 36. Eurocor Tech Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Eurocor Tech Recent Developments/Updates
Table 38. MedAlliance Basic Information, Manufacturing Base and Competitors
Table 39. MedAlliance Major Business
Table 40. MedAlliance Sirolimus Eluting Coronary Stent Product and Services
Table 41. MedAlliance Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. MedAlliance Recent Developments/Updates
Table 43. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 44. Boston Scientific Major Business
Table 45. Boston Scientific Sirolimus Eluting Coronary Stent Product and Services
Table 46. Boston Scientific Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Boston Scientific Recent Developments/Updates
Table 48. Abbott Basic Information, Manufacturing Base and Competitors
Table 49. Abbott Major Business
Table 50. Abbott Sirolimus Eluting Coronary Stent Product and Services
Table 51. Abbott Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Abbott Recent Developments/Updates
Table 53. Vasmed Basic Information, Manufacturing Base and Competitors
Table 54. Vasmed Major Business
Table 55. Vasmed Sirolimus Eluting Coronary Stent Product and Services
Table 56. Vasmed Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Vasmed Recent Developments/Updates
Table 58. Alvimedica Basic Information, Manufacturing Base and Competitors
Table 59. Alvimedica Major Business
Table 60. Alvimedica Sirolimus Eluting Coronary Stent Product and Services
Table 61. Alvimedica Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Alvimedica Recent Developments/Updates
Table 63. B. Braun Basic Information, Manufacturing Base and Competitors
Table 64. B. Braun Major Business
Table 65. B. Braun Sirolimus Eluting Coronary Stent Product and Services
Table 66. B. Braun Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. B. Braun Recent Developments/Updates
Table 68. Balton Basic Information, Manufacturing Base and Competitors
Table 69. Balton Major Business
Table 70. Balton Sirolimus Eluting Coronary Stent Product and Services
Table 71. Balton Sirolimus Eluting Coronary Stent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Balton Recent Developments/Updates
Table 73. Global Sirolimus Eluting Coronary Stent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Sirolimus Eluting Coronary Stent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Sirolimus Eluting Coronary Stent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Sirolimus Eluting Coronary Stent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Sirolimus Eluting Coronary Stent Production Site of Key Manufacturer
Table 78. Sirolimus Eluting Coronary Stent Market: Company Product Type Footprint
Table 79. Sirolimus Eluting Coronary Stent Market: Company Product Application Footprint
Table 80. Sirolimus Eluting Coronary Stent New Market Entrants and Barriers to Market Entry
Table 81. Sirolimus Eluting Coronary Stent Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Sirolimus Eluting Coronary Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Sirolimus Eluting Coronary Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Sirolimus Eluting Coronary Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Sirolimus Eluting Coronary Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Sirolimus Eluting Coronary Stent Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Sirolimus Eluting Coronary Stent Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Sirolimus Eluting Coronary Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Sirolimus Eluting Coronary Stent Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Sirolimus Eluting Coronary Stent Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Sirolimus Eluting Coronary Stent Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Sirolimus Eluting Coronary Stent Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Sirolimus Eluting Coronary Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Sirolimus Eluting Coronary Stent Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Sirolimus Eluting Coronary Stent Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Sirolimus Eluting Coronary Stent Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Sirolimus Eluting Coronary Stent Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Sirolimus Eluting Coronary Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Sirolimus Eluting Coronary Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Sirolimus Eluting Coronary Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Sirolimus Eluting Coronary Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Sirolimus Eluting Coronary Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Sirolimus Eluting Coronary Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Sirolimus Eluting Coronary Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Sirolimus Eluting Coronary Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Sirolimus Eluting Coronary Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Sirolimus Eluting Coronary Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Sirolimus Eluting Coronary Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Sirolimus Eluting Coronary Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Sirolimus Eluting Coronary Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Sirolimus Eluting Coronary Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Sirolimus Eluting Coronary Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Sirolimus Eluting Coronary Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Sirolimus Eluting Coronary Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Sirolimus Eluting Coronary Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Sirolimus Eluting Coronary Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Sirolimus Eluting Coronary Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Sirolimus Eluting Coronary Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Sirolimus Eluting Coronary Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Sirolimus Eluting Coronary Stent Raw Material
Table 141. Key Manufacturers of Sirolimus Eluting Coronary Stent Raw Materials
Table 142. Sirolimus Eluting Coronary Stent Typical Distributors
Table 143. Sirolimus Eluting Coronary Stent Typical Customers
List of Figures
Figure 1. Sirolimus Eluting Coronary Stent Picture
Figure 2. Global Sirolimus Eluting Coronary Stent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Sirolimus Eluting Coronary Stent Consumption Value Market Share by Type in 2022
Figure 4. Balloon Diameter 2.25-3 mm Examples
Figure 5. Balloon Diameter 3-4 mm Examples
Figure 6. Others Examples
Figure 7. Global Sirolimus Eluting Coronary Stent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Sirolimus Eluting Coronary Stent Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Examples
Figure 10. Clinics Examples
Figure 11. Others Examples
Figure 12. Global Sirolimus Eluting Coronary Stent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Sirolimus Eluting Coronary Stent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Sirolimus Eluting Coronary Stent Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Sirolimus Eluting Coronary Stent Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Sirolimus Eluting Coronary Stent Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Sirolimus Eluting Coronary Stent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Sirolimus Eluting Coronary Stent Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Sirolimus Eluting Coronary Stent Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Sirolimus Eluting Coronary Stent Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Sirolimus Eluting Coronary Stent Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Sirolimus Eluting Coronary Stent Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Sirolimus Eluting Coronary Stent Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Sirolimus Eluting Coronary Stent Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Sirolimus Eluting Coronary Stent Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Sirolimus Eluting Coronary Stent Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Sirolimus Eluting Coronary Stent Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Sirolimus Eluting Coronary Stent Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Sirolimus Eluting Coronary Stent Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Sirolimus Eluting Coronary Stent Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Sirolimus Eluting Coronary Stent Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Sirolimus Eluting Coronary Stent Consumption Value Market Share by Region (2018-2029)
Figure 54. China Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Sirolimus Eluting Coronary Stent Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Sirolimus Eluting Coronary Stent Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Sirolimus Eluting Coronary Stent Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Sirolimus Eluting Coronary Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Sirolimus Eluting Coronary Stent Market Drivers
Figure 75. Sirolimus Eluting Coronary Stent Market Restraints
Figure 76. Sirolimus Eluting Coronary Stent Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Sirolimus Eluting Coronary Stent in 2022
Figure 79. Manufacturing Process Analysis of Sirolimus Eluting Coronary Stent
Figure 80. Sirolimus Eluting Coronary Stent Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Cardionovum Concept Medical BIOTRONIK Terumo Europe Meril Life Sciences eucatech AG Eurocor Tech MedAlliance Boston Scientific Abbott Vasmed Alvimedica B. Braun Balton
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>